Volume 21, Number 5—May 2015
Research
Transmission of Hepatitis C Virus among Prisoners, Australia, 2005–2012
Table 2
Probable HCV transmission events identified by using phylogenetic analysis, spatiotemporal information, and risk behavior information, New South Wales, Australia, 2005–2012*
Cluster | Transmission, participant ID no. | Period of co-location | Prison ID† | Patient ID | Est. date of infection | HCV genotype | ATSI | Continuously in prison‡ | Equipment sharing§ | OST§ | Heroin use§ |
---|---|---|---|---|---|---|---|---|---|---|---|
A | 315 → 117 | 2007 Dec 31–2008 Jan 22 | AT | 315 | 2007 Oct 30 | 1a | No | Yes | Yes | No | No |
117 | 2008 Feb 27 | 1a | No | No | Yes | No | Yes | ||||
315 → 461 | 2008 Jun 29–Jul 11 | AE | 315 | 2007 Oct 30 | 1a | No | Yes | Yes | No | No | |
2008 Sep 24–Oct 1 | 461 | 2008 Oct 6 | 1a | No | No | Yes | No | Yes | |||
B | 304 → 357 | 2007 Oct 26–Nov 23 | AB | 304 | 2007 Apr 17 | 3a | No | No | No | No | No |
357 | 2008 Nov 11 | 3a | No | Yes | Yes | No | Yes | ||||
C | 302 → 426 | 2008 Dec 9–18 | AP | 302§ | 2007 Oct 11 | 3a | Yes | No | Yes | No | No |
426 | 2008 Dec 21 | 3a | Yes | No | Yes | Yes | No |
*All prisoners were injection drug users during the period of co-location. ATSI, Aboriginal and/or Torres Strait Islander descent; est., estimated; HCV, hepatitis C virus; ID, identification; OST, opioid substitution therapy.
†Prisons are identified by codes for de-identification purposes.
‡Continuously in prison 6 mo before estimated date of infection.
§Female patient. All others were male.
1Additional HITS-p investigators are listed at the end of this article.